Hims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth Strategy

Hims & Hers Health, Inc. (NYSE:HIMS) announced on Tuesday that it plans to acquire Zava, a European telehealth platform, as part of its international expansion efforts.

The company stated that the deal is expected to be finalized by mid-year. Although the financial terms weren’t revealed, more details will be included in upcoming financial filings once the transaction is completed.

Hims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth Strategy

A nurse in a telehealth platform talking with a patient on video call for consultation.

Hims & Hers Health, Inc. (NYSE:HIMS) previously entered the international market in 2021 with its acquisition of Honest Health, a London-based health platform.

With the addition of Zava, the company will extend its services to Ireland, France, and Germany, increasing its active customer base by around 50%, gaining 1.3 million new users on top of its current 2.4 million subscribers.

Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum stated the following in a CNBC interview:

“We’re excited to take this moment to really accelerate both the European expansion, but also use this platform as an accelerant as we move into more markets. Early traction in the UK gives us confidence that we can scale out platform globally and extend out mission to help people around the world.”

David Meinertz, CEO of Zava and founder of the platform in 2011, said the acquisition will help ease the strain on Europe’s overburdened healthcare system.

Hims & Hers Health, Inc. (NYSE:HIMS) is a telehealth service that connects users with medical professionals for consultations and provides prescriptions for a range of health conditions.

The stock is gaining traction, surging by nearly 125% since the start of 2025.

While we acknowledge the potential of HIMS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HIMS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: Why These Energy Stocks Are Gaining This Week and 10 Best Income Stocks to Invest in Now

Disclosure. None.